Clinical Trials Browser

Phase 1/2 × Neoplasms × Dacarbazine × Clear all

NCT00246012 2013-08-19

A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma

Phase 1/2 Completed

144 enrolled 34 charts

Melanoma, Neoplasms